In vitro active ingredient liberation of five commercial prednisolone preparations in tablet form
Hagemann, P.
Pharmaceutica Acta Helvetiae 53(5): 133-135
1978
ISSN/ISBN: 0031-6865 PMID: 724724 Document Number: 137334
Document emailed within 1 workday
Related Documents
Horsch, W.; Löschburg, M. 1981: Contributions to the liberation of drugs from suspension ointments. Part 13: the effects of physiochemical factors on the liberation of prednisolone from oleogels Die Pharmazie 36(12): 823-827Horsch, W.; Mette, B. 1974: In vitro liberation of hydroxyquinoline sulfate from different skin preparations Die Pharmazie 29(8): 546-547
Theiss, U.; Gebhardt, E.; Müller, J. 1992: The bioequivalence of two different batches of two nifedipine controlled-release preparations with deficient batch conformity in in vitro liberation studies Arzneimittel-Forschung 42(5): 629-632
Kapp, J.F.; Gliwitzki, B.; Josefiuk, P.; Weishaupt, W. 1977: Dermal and systemic side effects of fluocortin butylester. Comparative skin tearing experiments with active principles from commercial preparations Arzneimittel-Forschung 27(11a): 2206-2213
Pár, A.; Paál, M.; Kádas, I.; Kerekes, E.; Jávor, T. 1983: Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study) Acta Medica Hungarica 40(1): 17-24
Selmeczi, B.; Kedvessy, G.; Nagy, G.; Pintyéné Hódi, K.; Tencova, A.; Kiszeleva, G. 1981: Influence of the technological procedure and additives on the dissolution rate and absorption of active ingredients. I. Physical properties of acetylsalicylic acid tablets and of the dissolution rate of the active ingredient Acta Pharmaceutica Hungarica 51(5): 222-227
Lorentzen, F.; Jorgensen, P.; Nielsen, E.; Nyberg, G.; Hvidt, S. 1973: Comparison between alprenolol in tablet form (Aptin) and in "sustained release" form (Aptin Durules) in angina pectoris Ugeskrift for Laeger 135(27): 1431-1438
Zeng, L.L.; Wang, G.Y.; Wang, D.X.; Chen, C.H.; Xu, S.Y. 1982: Studies on the active ingredient of Curcuma aromatica Salisb and its effects Yao Xue Xue Bao 17(12): 946-950
Rao, M.S.; Nair, P.; Pratap, C. 1973: Induction of mutations by thioridazine hydrochloride, an active ingredient of Mellaril Indian Journal of Experimental Biology 11(5): 403-404
Russell, A.S.; Aghazadeh-Habashi, A.; Jamali, F. 2002: Active ingredient consistency of commercially available glucosamine sulfate products Journal of Rheumatology 29(11): 2407-2409
Przybilla, B.; Schwab, U.; Hölzle, E.; Ring, J. 1983: Contact sensitization to an antiperspirant with the active ingredient propantheline bromide Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 34(9): 459-462
Keve, T.; Zsadon, B.; Galambos, J.; Barta, K. 1987: Development of a new active ingredient for the treatment of psoriasis with synthesis from plant raw materials: RGH-4417 Acta Pharmaceutica Hungarica 57(5): 199-207
Liu, C.-L.; Yin, Y.; Zhang, S.-H.; Li, Q.; Chen, M.; Guo, X. 2014: Study on correlation between trace elements and active ingredient in glycyrrhizae radix et rhizome Zhongguo Zhong Yao Za Zhi 39(17): 3335-3338
Egermann, H. 1985: Calculation of materials of random mixtures of drug forms with minor proportions of active ingredient (1.) Pharmaceutica Acta Helvetiae 60(12): 322-325
Miseta, M.; Kedvessy, G.; Selmeczi, B. 1983: Influence of the pressing force on the physical features of sulfathiazole tablets and the dissolution rate of the active ingredient Die Pharmazie 38(5): 326-327
Zhou, W-bin.; Lin, L.; Li, Z-yong.; Bi, T.; Ye, T-yuan.; Ma, C-qiang.; Bao Hong-juan; Wang, H-ping.; Zhang, B-xia.; Song, K-kui.; Li, Y-wen.; Wang, Y. 2015: Study on active ingredient and mechanism in preventing vascular dementia of Tianzhusan coming from Tujia medicine Zhongguo Zhong Yao Za Zhi 40(13): 2668-2673
Rubinstein, M.H.; Wells, J.I. 1977: The application of conductivity measurements to evaluate commercial digoxin tablet formulations Pharmaceutica Acta Helvetiae 52(5): 112-115
Giannattasio, F.; Salvio, A.; Varriale, M.; Picciotto, F.P.; Di Costanzo, G.G.; Visconti, M. 2002: Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 17(3): 180-184
Tozo, G.C.G.; Salgado, H.ér.R.N. 2006: Determination of lomefloxacin in tablet preparations by liquid chromatography Journal - Association of Official Analytical Chemists 89(5): 1305-1308
Muravĭov, I.O.; Kononikhina, N.F. 1980: Physicochemical aspects of the liberation of water-soluble preparations from hydrophobic ointment bases Farmatsevtychnyi Zhurnal 2: 57-60